Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

Weight-loss injections such as Ozempic and Wegovy are helping millions lose weight quickly. But could rapid weight loss affect bone strength and increase gout risk?

Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined recent regulatory, ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 ...

India, March 19 -- Women with cancer show a 21% lower risk of death than men but experience a 12% higher risk of severe treatment-related side effects, revealing a critical survival and toxicity ...

HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical--stage biotech company advancing RNA medicines, today announced that the U.S. Food and ...

South Korea: A study published in The Journal of Rheumatology found that febuxostat effectively reduces and maintains serum ...

GLP-1 receptor agonist use in adults with concurrent type 2 diabetes and obesity was associated with increased risk for ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

Treatment with GLP-1 RAs for T2D and obesity is associated with increased risk for osteoporosis, gout, and osteomalacia compared with nonuse.

John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor ...